Antiviral prophylaxis in patients with solid tumours and haematological malignancies—update of the Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Medical Oncology (DGHO)

Reactivation of viral infections is common in patients with solid tumour or haematological malignancy. Incidence and severity depend on the extent of cellular immunosuppression. Antiviral prophylaxis may be effective to prevent viral reactivation. In 2006, the Infectious Diseases Working Party of Ge...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Ann Hematol
Autors principals: Sandherr, Michael, Hentrich, Marcus, von Lilienfeld-Toal, Marie, Massenkeil, Gero, Neumann, Silke, Penack, Olaf, Biehl, Lena, Cornely, Oliver A.
Format: Artigo
Idioma:Inglês
Publicat: Springer Berlin Heidelberg 2015
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4525190/
https://ncbi.nlm.nih.gov/pubmed/26193852
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00277-015-2447-3
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars